Evidence map›Paper›PMID 27207978›Full record

ReviewToxicological sciences : an official journal of the Society of Toxicology2016

Setting Occupational Exposure Limits for Genotoxic Substances in the Pharmaceutical Industry.

Ester Lovsin Barle, Gian Christian Winkler, Susanne Glowienke, Azeddine Elhajouji, Jana Nunic, Hans-Joerg Martus

Abstract readReview
In one paragraph

Review in Toxicological sciences : an official journal of the Society of Toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ester Lovsin Barle*Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland ester.lovsin_barle@novartis.com.
Gian Christian WinklerNovartis Pharma AG NIBR, Postfach, CH-4002 Basel, Switzerland; and.
Susanne GlowienkeNovartis Pharma AG NIBR, Postfach, CH-4002 Basel, Switzerland; and.
Azeddine ElhajoujiNovartis Pharma AG NIBR, Postfach, CH-4002 Basel, Switzerland; and.
Jana NunicLek Pharmaceuticals D.D, Verovškova 57, 1526 Ljubljana, Slovenia.
Hans-Joerg MartusNovartis Pharma AG NIBR, Postfach, CH-4002 Basel, Switzerland; and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the pharmaceutical industry, genotoxic drug substances are developed for life-threatening indications such as cancer. Healthy employees handle these substances during research, development, and manufacturing; therefore, safe handling of genotoxic substances is essential. When an adequate preclinical dataset is available, a risk-based decision related to exposure controls for manufacturing is made following a determination of safe health-based limits, such as an occupational exposure limit (OEL). OELs are calculated for substances based on a threshold dose-response once a threshold is identified. In this review, we present examples of genotoxic mechanisms where thresholds can be demonstrated and OELs can be calculated, including a holistic toxicity assessment. We also propose a novel approach for inhalation Threshold of Toxicological Concern (TTC) limit for genotoxic substances in cases where the database is not adequate to determine a threshold.

Indexed as

DNA DamageAnimalsDose-Response Relationship, DrugDrug IndustryHumansInhalation ExposureModels, BiologicalMutagensNeoplasmsOccupational DiseasesOccupational ExposureOccupational HealthRisk AssessmentMutagensacceptable riskgenotoxicityoccupational exposure limitthresholdTTC

Identifiers

PMID27207978
PMCPMC4914798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.